Affordable Access

Publisher Website

Synthesis and characterization of daunorubicin modified ZnO/PVP nanorods and its photodynamic action

Authors
Journal
Journal of Photochemistry and Photobiology A Chemistry
1010-6030
Publisher
Elsevier
Publication Date
Volume
252
Identifiers
DOI: 10.1016/j.jphotochem.2012.11.017
Keywords
  • Zno Nano
  • Surface Modification
  • Daunorubicin
  • Singlet Oxygen
  • Photoinactivation
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Nanomaterials have widely been used in the field of biological and biomedicine, such as tissue imaging, diagnosis and cancer therapy. The aim of this study is to investigate cytotoxicity and photodynamic effect of combined application of polyvinyl pyrrolidone (PVP) modified ZnO nanorods with anticancer drug daunorubicin (DNR) in photodynamic therapy (PDT). Daunorubicin (DNR) has a broad spectrum of anticancer activity, but it is limited in clinical application due to its serious side effects. In DNR-ZnO/PVP nanocomposites, ZnO/PVP nanorods act as drug carrier of DNR in drug delivery system (DNR-ZnO/PVP nanocomposites). This drug delivery system induced remarkable improvement in anticancer activity, as demonstrated by MTT assay using 3-(4,5-dimethylthiazol-2yl)-2,5 diphenyl tetrazolium bromide (MTT reagent). This has been also demonstrated by antibacterial activity and DNA cleavage study. The findings suggest that DNR delivery strategy is a promising approach to cancer therapy.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Synthesis and characterization of doxorubicin modi...

on Journal of Photochemistry and... Nov 05, 2012

Low temperature synthesis of ZnO nanorods by using...

on Physica B Condensed Matter Jan 01, 2009

Synthesis and characterization of PVP/TbL(phen)0.5...

on Journal of Nanoscience and Nan... November 2011

Synthesis and characterization of ZnO nanorods

on Journal of Crystal Growth Jan 01, 2003
More articles like this..